EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis

Jiani Yi iD, Mengting Wu iD, Zhihong Zheng iD, Qing Zhou iD, Xufan Li iD, Yan Lu iD, Pengyuan Liu iD

Journal of Gynecologic Oncology · 2023

DOI: 10.3802/jgo.2023.34.e71 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2023. Verfasst von Jiani Yi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Sir Run Run Shaw Hospital and Institute of Translatio…. Hauptthemen laut MEDLINE: beta Catenin, Ovarian Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NSFC, Key Research & Development Program of Zhejiang Province, Key Program of Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: More than 75% of ovarian cancer patients are diagnosed at advanced stages and die of tumor cell metastasis. This study aimed to identify new epigenetic and transcriptomic alterations associated with ovarian cancer metastasis. METHODS: Two cell sublines with low- and high-metastasis potentials were derived from the ovarian cancer cell line A2780. Genome-wide DNA methylome and transcriptome profiling were carried out in these two sublines by Reduced Representation Bisulfite Sequencing and RNA-seq technologies. Cell-based assays were conducted to support the clinical findings. RESULTS: There are distinct DNA methylation and gene expression patterns between the two cell sublines with low- and high-metastasis potentials. Integrated analysis identified 33 methylation-induced genes potentially involved in ovarian cancer metastasis. The DNA methylation patterns of two of them (i.e., SFRP1 and LIPG) were further validated in human specimens, indicating that they were hypermethylated and downregulated in peritoneal metastatic ovarian carcinoma compared to primary ovarian carcinoma. Patients with lower SFRP1 and LIPG expression tend to have a worse prognosis. Functionally, knockdown of SFRP1 and LIPG promoted cell growth and migration, whereas their overexpression resulted in the opposite effects. In particular, knockdown of SFRP1 could phosphorylate GSK3β and increase β-catenin expression, leading to deregulated activation of the Wnt/β-catenin signaling. CONCLUSION: Many systemic and important epigenetic and transcriptomic alterations occur in the progression of ovarian cancer. In particular, epigenetic silencing of SFRP1 and LIPG is a potential driver event in ovarian cancer metastasis. They can be used as prognostic biomarkers and therapeutic targets for ovarian cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta CateninOvarian NeoplasmsHumansFemaleTranscriptomeEpigenomeCell Line, TumorDNA MethylationGene Expression Regulation, NeoplasticMembrane ProteinsIntercellular Signaling Peptides and ProteinsLipaseSecreted Frizzled-Related Proteins

Stichwörter der Autor:innen

DNA MethylationMetastasisOvarian CancerRNA-SeqTumor Suppressor Gene

Substanzen

beta CateninMembrane ProteinsIntercellular Signaling Peptides and ProteinsLipaseSFRP1 protein, humanSecreted Frizzled-Related ProteinsLIPG protein, human

Autor:innen und Institutionen

  • Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Department of Gynecologic Oncology, Women's Hospital and Institute of Translational Medicine, Zhejiang University S…
  • Cancer Center, Zhejiang University, Hangzhou, China.
  • Cancer Center, Zhejiang University, Hangzhou, China. pyliu@zju.edu.cn.

ORCID-Profile: Jiani Yi, Mengting Wu, Zhihong Zheng, Qing Zhou, Xufan Li, Yan Lu, Pengyuan Liu

Förderung

  • NSFC
  • Key Research & Development Program of Zhejiang Province
  • Key Program of Zhejiang Provincial Natural Science Foundation of China
  • Medical Health Science and Technology Key Project of Zhejiang Provincial Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Yi, J., Wu, M., Zheng, Z., Zhou, Q., Li, X., Lu, Y., & Liu, P. (2023). Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2023.34.e71

Vancouver

Yi J, Wu M, Zheng Z, Zhou Q, Li X, Lu Y, et al. Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis. Journal of Gynecologic Oncology. 2023. doi:10.3802/jgo.2023.34.e71

BibTeX
@article{Yi2023,
  author = {Yi, Jiani and Wu, Mengting and Zheng, Zhihong and Zhou, Qing and Li, Xufan and Lu, Yan and Liu, Pengyuan},
  title = {Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis},
  journal = {Journal of Gynecologic Oncology},
  year = {2023},
  doi = {10.3802/jgo.2023.34.e71}
}
Kostenlos starten →